Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Common Coverage Denials and Approval Barriers Blue Cross Blue Shield frequently denies semaglutide coverage based on body mass index (BMI) thresholds, requiring patients to demonstrate a BMI of 30 or higher, or 27 with weight-related comorbidities
patients interested in next-generation triple-receptor therapy can access GLP-Squared (dual semaglutide + tirzepatide) immediately at $289/mo (or $249/mo on the 3-month plan) through licensed 503A compounding
BCBSTX plans typically cover IOPs, ensuring families like yours can access this effective treatment option
6 Usually limited to age 13 years and above, bariatric surgery has demonstrated success but still has limited uptake (Table 1)
US$ 24.17
US$ 28.19
US$ 28.56
